Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,286 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1)

NCT02414139

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +16 more
Locations
  • Pacific Shores Medical Group SC Long Beach, California, United States
  • University Of California Los Angeles Dept of Onc Los Angeles, California, United States
  • University of California Irvine Medical Center Chao Family Chao Family Comp Cancer Center Orange, California, United States
  • H Lee Moffitt Cancer Center and Research Institute . Tampa, Florida, United States
View all 95 locations
View Trial Details
Completed

A Study of HC-5404-FU to Establish the Maximum Tolerated Dose (MTD)

NCT04834778

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +36 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • HealthPartners Cancer Care Center Saint Paul, Minnesota, United States
  • Baylor University Medical Center Dallas, Texas, United States
  • The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States
View Trial Details
Completed

A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer

NCT04069026

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Greenville Health System Greenville, South Carolina, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • South Texas Accelerated Research Therapeutics | START San Antonio San Antonio, Texas, United States
View all 17 locations
View Trial Details
Completed

BMS-986012 in Relapsed/Refractory SCLC

NCT02247349

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Lung Diseases, +8 more
Locations
  • Local Institution - 0004 New York, United States
  • Local Institution - 0001 Durham, North Carolina, United States
  • Local Institution - 0021 Winston-Salem, North Carolina, United States
  • Local Institution - 0020 St Leonards, New South Wales, Australia
View all 16 locations
View Trial Details
Completed

A Dose Escalation and Cohort Expansion Study of Subcutaneously-Administered Cytokine ALKS 4230 (Nemvaleukin Alfa) as a Single Agent and in Combination With Anti-PD-1 Antibody (Pembrolizumab) in Subjects With Select Advanced or Metastatic Solid Tumors (ARTISTRY-2)

NCT03861793

Conditions
Adenocarcinoma, Advanced Solid Tumors, Bronchial Neoplasms, +18 more
Locations
  • Mural Oncology Investigational Site Los Angeles, California, United States
  • Mural Oncology Investigational Site Los Angeles, California, United States
  • Mural Oncology Investigational Site Washington D.C., District of Columbia, United States
  • Mural Oncology Investigational Site Atlanta, Georgia, United States
View all 48 locations
View Trial Details

Related conditions